- Regular updates
- No spam
Ghent-based Innogenetics, one of the pioneering biotech firms in Flanders, recently changed hands. New owner is the Japanese diagnostics company Fujirebio which bought the firm for EUR 86 million from former American owner Abbot Laboratories.
Innogenetics' managing director said: "Innogenetics had recently narrowed its focus and was profitable in 2009. Our first half-year results were outstanding. And our new owner's activities and ours are highly complementary."
Innogenetics is one of Flanders' pioneers in the biotech industry. The firm specializes in the development and marketing of diagnostic assays in the fields of Infectious Diseases, Genetic Testing, Transplantation, Neurodegeneration and Oncology, with a special focus on molecular diagnostics and multiparameter testing. (Reported by De Tijd and De Standaard newspaper)
More info: Fujirebio or Innogenetics - www.fdi.com/index.html - www.innogenetics.com/default.html
Reported by
FIT10 August 2010